West Pharmaceutical Services Stock Today

WST Stock  USD 377.33  0.03  0.01%   

Performance

5 of 100

 
Weak
 
Strong
Modest

Odds Of Distress

Less than 1

 
High
 
Low
Very Small
West Pharmaceutical is selling for under 377.33 as of the 19th of April 2024; that is -0.008 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 372.41. West Pharmaceutical has a very small chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. Equity ratings for West Pharmaceutical Services are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
13th of January 1978
Category
Healthcare
Classification
Health Care
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. West Pharmaceutical Services, Inc. The company has 73.21 M outstanding shares of which 1.13 M shares are at this time shorted by investors with about 2.3 days to cover. More on West Pharmaceutical Services

West Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. West Pharmaceutical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding West Pharmaceutical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEOEric Green
Thematic Ideas
(View all Themes)
Old NameWistil S.A.
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NYSE Composite, SP 500 Index, Rubber and Plastic Products, Obamacare Repeal, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors)
Average Analyst Recommendation
Analysts covering West Pharmaceutical report their recommendations after researching West Pharmaceutical's financial statements, talking to executives and customers, or listening in on West Pharmaceutical's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering West Pharmaceutical. The West consensus assessment is calculated by taking the average forecast from all of the analysts covering West Pharmaceutical.
Financial Strength
Based on the analysis of West Pharmaceutical's profitability, liquidity, and operating efficiency, West Pharmaceutical Services is performing exceptionally good at this time. It has a great probability to report excellent financial results in May. Financial strength of West Pharmaceutical is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Return On Assets0.160.155
Sufficiently Up
Slightly volatile
Asset Turnover0.980.7703
Significantly Up
Pretty Stable
Gross Profit Margin0.260.3828
Way Down
Slightly volatile
Total Current Liabilities705.4 M671.8 M
Sufficiently Up
Slightly volatile
Non Current Liabilities Total307.8 M276.7 M
Moderately Up
Very volatile
Total AssetsB3.8 B
Sufficiently Up
Slightly volatile
Total Current AssetsB1.9 B
Sufficiently Up
Slightly volatile
Total Cash From Operating Activities815.3 M776.5 M
Sufficiently Up
Slightly volatile
West Pharmaceutical's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to West Pharmaceutical's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand West Pharmaceutical's financial leverage. It provides some insight into what part of West Pharmaceutical's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on West Pharmaceutical's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how West Pharmaceutical deploys its capital and how much of that capital is borrowed.
Liquidity
West Pharmaceutical cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 309 M in debt with debt to equity (D/E) ratio of 0.12, which may show that the company is not taking advantage of profits from borrowing. West Pharmaceutical has a current ratio of 3.72, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist West Pharmaceutical until it has trouble settling it off, either with new capital or with free cash flow. So, West Pharmaceutical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like West Pharmaceutical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for West to invest in growth at high rates of return. When we think about West Pharmaceutical's use of debt, we should always consider it together with cash and equity.

Depreciation

144.16 Million
West Pharmaceutical Services (WST) is traded on New York Stock Exchange in USA. It is located in 530 Herman O. West Drive, Exton, PA, United States, 19341-1147 and employs 10,600 people. West Pharmaceutical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 27.78 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate West Pharmaceutical's market, we take the total number of its shares issued and multiply it by West Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. West Pharmaceutical runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 73.21 M outstanding shares of which 1.13 M shares are at this time shorted by investors with about 2.3 days to cover. West Pharmaceutical Services has about 894.3 M in cash with 776.5 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.85.
Check West Pharmaceutical Probability Of Bankruptcy
Ownership Allocation
West Pharmaceutical owns a total of 73.21 Million outstanding shares. The majority of West Pharmaceutical outstanding shares are owned by institutional investors. These institutions are usually referred to as non-private investors looking to purchase positions in West Pharmaceutical to benefit from reduced commissions. Consequently, other corporate entities are subject to a different set of regulations than regular investors in West Pharmaceutical Services. Please pay attention to any change in the institutional holdings of West Pharmaceutical as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check West Ownership Details

West Stock Price Odds Analysis

Attributed to a normal probability distribution, the odds of West Pharmaceutical jumping above the current price in 90 days from now is about 48.17%. The West Pharmaceutical Services probability density function shows the probability of West Pharmaceutical stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon West Pharmaceutical has a beta of 0.63. This entails as returns on the market go up, West Pharmaceutical average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding West Pharmaceutical Services will be expected to be much smaller as well. Additionally, west Pharmaceutical Services has an alpha of 0.1145, implying that it can generate a 0.11 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 377.33HorizonTargetOdds Above 377.33
51.60%90 days
 377.33 
48.17%
Based on a normal probability distribution, the odds of West Pharmaceutical to move above the current price in 90 days from now is about 48.17 (This West Pharmaceutical Services probability density function shows the probability of West Stock to fall within a particular range of prices over 90 days) .

West Stock Institutional Holders

Institutional Holdings refers to the ownership stake in West Pharmaceutical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of West Pharmaceutical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing West Pharmaceutical's value.
InstituionRecorded OnShares
T. Rowe Price Investment Management,inc.2023-12-31
1.2 M
Durable Capital Partners Lp2023-12-31
1.1 M
Morgan Stanley - Brokerage Accounts2023-12-31
M
Bamco Inc2023-12-31
997.8 K
Amvescap Plc.2023-12-31
942.7 K
Jpmorgan Chase & Co2023-12-31
880.1 K
Goldman Sachs Group Inc2023-12-31
868.4 K
Norges Bank2023-12-31
852.7 K
Northern Trust Corp2023-12-31
771.6 K
Vanguard Group Inc2023-12-31
M
Blackrock Inc2023-12-31
7.8 M
View West Pharmaceutical Diagnostics

West Pharmaceutical Historical Income Statement

West Pharmaceutical Services Income Statement is one of the three primary financial statements used for reporting West's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of West Pharmaceutical revenue and expense. West Pharmaceutical Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, West Pharmaceutical's Total Operating Expenses is comparatively stable compared to the past year. Income Before Tax is likely to gain to about 732.9 M in 2024, whereas Selling General Administrative is likely to drop slightly above 194.7 M in 2024. View More Fundamentals

West Stock Against Markets

Picking the right benchmark for West Pharmaceutical stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in West Pharmaceutical stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for West Pharmaceutical is critical whether you are bullish or bearish towards West Pharmaceutical Services at a given time. Please also check how West Pharmaceutical's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in West Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Volatility Now

   

Portfolio Volatility

Check portfolio volatility and analyze historical return density to properly model market risk
All  Next Launch Module

West Pharmaceutical Corporate Directors

West Pharmaceutical corporate directors refer to members of a West Pharmaceutical board of directors. The board of directors generally takes responsibility for the West Pharmaceutical's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of West Pharmaceutical's board members must vote for the resolution. The West Pharmaceutical board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Mark ButhmanIndependent DirectorProfile
Deborah TannerIndependent DirectorProfile
John WeilandIndependent DirectorProfile
William FeeheryIndependent DirectorProfile

How to buy West Stock?

Before investing in West Pharmaceutical, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in West Pharmaceutical. To buy West Pharmaceutical stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of West Pharmaceutical. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase West Pharmaceutical stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located West Pharmaceutical Services stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased West Pharmaceutical Services stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as West Pharmaceutical Services, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy West Stock please use our How to Invest in West Pharmaceutical guide.

Already Invested in West Pharmaceutical Services?

The danger of trading West Pharmaceutical Services is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of West Pharmaceutical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than West Pharmaceutical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile West Pharmaceutical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether West Pharmaceutical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if West Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about West Pharmaceutical Services Stock. Highlighted below are key reports to facilitate an investment decision about West Pharmaceutical Services Stock:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in West Pharmaceutical Services. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for West Stock analysis

When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Is West Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of West Pharmaceutical. If investors know West will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about West Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.334
Dividend Share
0.77
Earnings Share
7.89
Revenue Per Share
39.701
Quarterly Revenue Growth
0.033
The market value of West Pharmaceutical is measured differently than its book value, which is the value of West that is recorded on the company's balance sheet. Investors also form their own opinion of West Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is West Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because West Pharmaceutical's market value can be influenced by many factors that don't directly affect West Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between West Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if West Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, West Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.